Since knockout of Sept4/Arts promotes the renewal of Lgr5+ intestinal stem cells and thus the regeneration of crypts (Koren et al., 2018), targeting intestinal ARTS could be a promising strategy for alleviating normal intestinal damage without affecting the pro-apoptotic activity of p53 in cancer cells. Here, TP53 is linked to cancer.